Information:
Error:
ID
24371
Description
Study part: Investigator’s Signature End of Study.An Open-Label Extension phase 3 Study with REQUIP (ropinirole) CR for Subjects from Studies 101468/165, 101468/168 and 101468/169 Patient Level Data. Study ID:101468/248, Clinical Study ID: 101468/248.
Keywords
Versions (1)
- 7/30/17 7/30/17 -
Copyright Holder
GlaxoSmithKline
Uploaded on
July 30, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Investigator’s Signature End of Study Ropinirole NCT00632736
Investigator’s Signature End of Study
- StudyEvent: ODM
Similar models
Investigator’s Signature End of Study
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Subject ID
Item
Subject ID
text
C2348585 (UMLS CUI [1])
consent
Item
I confirm that I have reviewed the data in this Case Report Form for this subject. All information entered by myself or my colleagues is, to the best of my knowledge, complete and accurate, as of the date below.
boolean
C1511481 (UMLS CUI [1])
Investigators signature
Item
Investigator’s Signature :
text
C2346576 (UMLS CUI [1])
Investigator name
Item
Investigator’s name
text
C2826892 (UMLS CUI [1])
Date
Item
Date
date
C0011008 (UMLS CUI [1])
No comments